Interaction between Posaconazole and Amphotericin B in Concomitant Treatment against <i>Candida albicans</i> In Vivo

Anthony Cacciapuoti, Judith Halpern, Christine Norris, Reena Patel, David Loebenberg

Antimicrobial Agents and Chemotherapy · 2005 · 26 citations · 19 references

DOIFull text

Open access

Concepts

Abstract

The interaction of posaconazole and amphotericin B was evaluated in concomitant treatment of Candida albicans systemic infections in immunocompetent mice by using four strains of C. albicans with different susceptibilities to fluconazole. Posaconazole and amphotericin B were each tested at four dose levels alone and in all possible combinations against each C. albicans strain. Survival curves of mice treated with combinations of posaconazole and amphotericin B were statistically compared with those of mice treated with the component monotherapies. Of the 64 total combinations evaluated against the C. albicans strains (16 combinations per strain), 20.3% were more effective in prolonging mouse survival than both of the monotherapies, 45.3% were more effective than one of the monotherapies, and 32.8% were similar to both monotherapies. No evidence of antagonism was observed between posaconazole and amphotericin B in this mouse model, consistent with in vitro results against the same strains.

References

19